PhotoCure ASAFRA:PHS -1.32%73 OCF Margin % is 0.29% as of Mar. 2026, which is 95% below its 10-year median of 6.36. GuruFocus rates FRA:PHS with a GF Score™ of 73/100 and a GF Value™ of €6.33 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 959 Drug Manufacturers companies, PhotoCure ASA ranks worse than 64.96% on this metric.
The historical rank and industry rank for PhotoCure ASA's OCF Margin % or its related term are showing as below:
FRA:PHS'
s OCF Margin % Range Over the Past 10 Years
Min: -15.63 Med: 6.36 Max: 14.61
Current: 3.32
During the past 13 years, the highest OCF Margin % of PhotoCure ASA was 14.61%. The lowest was -15.63%. And the median was 6.36%.
FRA:PHS's OCF Margin % is ranked worse than 64.96% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs FRA:PHS: 3.32
PhotoCure ASA OCF Margin % Related Terms
PhotoCure ASA OCF Margin % Historical Data
* Premium members only.
The historical data trend for PhotoCure ASA's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHS vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PhotoCure ASA OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's OCF Margin % distribution charts can be found below:
* The bar in red indicates where PhotoCure ASA's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PhotoCure ASA (FRA:PHS) has a OCF Margin % of 0.29% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhotoCure ASA and its competitors. This is 95% below median its historical median of 6.36. According to the industry distribution chart, PhotoCure ASA ranks #623 out of 959 companies in the Drug Manufacturers industry, placing it in the top 65%.
Is PhotoCure ASA's OCF Margin % too high?
PhotoCure ASA's current OCF Margin % of 0.29% is 95% below median its 10-year median of 6.36. The Drug Manufacturers industry median OCF Margin % is 9.94. PhotoCure ASA's value of 0.29% is 97.1% below this industry median. Based on the distribution chart, PhotoCure ASA ranks #623 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, PhotoCure ASA has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PhotoCure ASA ranks #623 out of 959 companies for OCF Margin %. This places PhotoCure ASA in the lower half of its industry. The industry median OCF Margin % is 9.94. PhotoCure ASA's value of 0.29% is 97.1% below this benchmark. While the company's 10-year median is 6.36 vs. the industry median of 9.94, PhotoCure ASA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PhotoCure ASA's current OCF Margin % of 0.29% is 97.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhotoCure ASA and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhotoCure ASA's current OCF Margin % is 0.29%, which is 95% below median its own 10-year median of 6.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (FRA:PHS) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.33, compared to a current price of €5.23 — trading 17.4% below its estimated fair value. The current OCF Margin % is 0.29%, which is 95% below median its 10-year median of 6.36 and 97.1% below the Drug Manufacturers industry median of 9.94. PhotoCure ASA's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PhotoCure ASA (FRA:PHS), the current OCF Margin % is 0.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PhotoCure ASA (FRA:PHS) Overvalued in 2026?
Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued.
The current stock price of €5.23 is trading 17.4% below its estimated GF Value™ of €6.33.
GuruFocus considers PhotoCure ASA to be Modestly Undervalued.
Key valuation signals for FRA:PHS:
OCF Margin %: 0.29% (95% below median its 10-year median of 6.36)
GF Value™: €6.33 vs. price of €5.23 (17.4% below fair value)
Industry Position: 97.1% below the Drug Manufacturers median (#623 of 959)
No single metric tells the full story. See the FRA:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
73GF Score
Get the complete analysis for FRA:PHS
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHS has been successfully added to your 
